Studies Show New Weight Loss Medications are the Real Deal, plus some data on what happens when we stop taking them

Back in 2021 we did an episode on Semaglutide, the then-recently-approved drug for weight loss that was originally approved for Type 2 diabetes. Since that episode another paper has come out on what happens to weight when the drug is discontinued, and another on Mounjaro, a drug approved for Type 2 diabetes. Let’s take a look.

 

Tiffany Doherty

Tiffany Doherty holds a doctorate in neuroscience and has a special interest in making scientific research accessible to everyone.

Hidden information below

Tiffany Doherty

Tiffany Doherty holds a doctorate in neuroscience and has a special interest in making scientific research accessible to everyone.

The Incidental Economist

the health services research blog

Boston-area website management by BKJ Productions
Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*